Swiss TPH is a highly respected academic institution within Switzerland, with a world-class reputation in global health research and action with a particular focus, expertise and experience in the area of malaria research, control and elimination. Our activities benefit from a commitment to interdisciplinary collaboration and a network of well-established partnerships in low- and middle-income countries in Africa, Asia and South America, as well as in Europe and North America.
Sharing Expertise with the Next Generation
Our institute includes international students who come to Swiss TPH to do their PhD or MSc. The students are carefully selected and often go back to their home country where they share their knowledge and typically go on to have high positions in local institutions. In this way we build capacity and a strong global network of well-educated individuals.
Swiss TPH Malaria Experts Contribute to several Global Health Consortia
With our services and advisory mandates we contribute our experience and expertise to the Basel area and Swiss community, as well as internationally. Our malaria experts are represented in leading consortia for global health such as the Roll Back Malaria Partnership, the Medicines for Malaria Venture (MMV), the Drugs for Neglected Diseases initiative (DINDi), the Bill & Melinda Gates Foundation and WHO/TDR, the Special Programme for Research and Training in Tropical Diseases as well as in advisory Committees of the World Health Organization. Swiss TPH together with Deloitte Consulting implemented the extensive consultative process that informed the development of the Second Global Malaria Action Plan “Action and Investment to defeat Malaria 2016-2030 (AIM) for a malaria-free world.”
The Global Malaria Technical and Training Support Package (GlobMal) aims at influencing global malaria policies and implementing WHO and Roll Back Malaria Partnership strategies to regional and country levels, with a focus on vector control, malaria case management, promoting multisectoral actions and strengthening technical capacities. The aim is to improve malaria program’s performance at country level ultimately to reduce the malaria burden and to expand malaria-free zones according to global goals set by WHO.
The Roll Back Malaria Partnership's Action and Investment to defeat Malaria 2016 – 2030 is a global advocacy document that highlights the devastating developmental impact of malaria and positions the disease in the era of the Sustainable Development Goals. Moreover, AIM makes the global case for investing to achieve the 2030 malaria goals and quantifies the return on investment to support resource mobilization efforts for malaria reduction and elimination at regional and country level.
Core to our modelling work is the development and use of an individual-based model of malaria transmission dynamics known as OpenMalaria. This model is an open-source tool for simulating the dynamics of malaria transmission and epidemiology, and the impact of interventions on health and economic outcomes. The model can simulate malaria in village or district size human populations, and has been used to address questions on disease dynamics and the use of interventions. Developed and maintained by the Disease Modelling Unit of Swiss TPH, our OpenMalaria model is used by a wide range of modellers worldwide. A new collaboration with the Bill & Melinda Gates Foundation supports the improvement and maintenance of OpenMalaria as well as the development of new mathematical malaria models. This project will provide model-based evidence for the Foundation and key partners towards improved investment and decision-making for better malaria control and elimination. Read more